Search results
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 2 days agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Up 4.3%
ETF DAILY NEWS· 6 hours agoJazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) was up 4.3% during trading on Friday . Needham & Company LLC reissued a “buy” rating and issued a $222.00 price objective ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 8 hours agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat ...
Steward Partners Investment Advisory LLC Purchases 384 Shares of West Pharmaceutical Services, Inc....
ETF DAILY NEWS· 5 hours agoSteward Partners Investment Advisory LLC raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 108.5% in the fourth quarter, HoldingsChannel.com ...
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Insider Weiss Amir sells 12,635 Shares – Knox Daily
Knox Daily· 4 days agoTeva- Pharmaceutical Industries Ltd. ADR’s recently made public that its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million on May 16 ...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 5 days agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Vanda Pharmaceuticals stock: why is it up 20% on Thursday?
Invezz· 3 days agoVanda Pharmaceuticals Inc (NASDAQ: VNDA) is up nearly 20% on Thursday following a report that Cycle ...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 20 hours agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 2 days agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
Justin Liby on Pharmaceutical Industry | JD Supra
JD Supra· 3 days agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra ...
